
Medplus Health (MEDPLUS) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
15.4B
Gross Profit
4.0B
26.12%
Operating Income
651.1M
4.22%
Net Income
423.4M
2.74%
EPS (Diluted)
₹3.53
Balance Sheet Metrics
Total Assets
33.6B
Total Liabilities
16.2B
Shareholders Equity
17.4B
Debt to Equity
0.93
Cash Flow Metrics
Revenue & Profitability Trend
Medplus Health Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 61.4B | 55.7B | 45.3B | 37.6B | 30.5B |
Cost of Goods Sold | 46.4B | 43.9B | 35.6B | 29.8B | 24.3B |
Gross Profit | 15.0B | 11.8B | 9.7B | 7.7B | 6.3B |
Gross Margin % | 24.4% | 21.2% | 21.4% | 20.6% | 20.5% |
Operating Expenses | |||||
Research & Development | - | - | - | - | 2.1M |
Selling, General & Administrative | - | 1.2B | 887.1M | 642.3M | 434.4M |
Other Operating Expenses | 2.8B | 1.1B | 934.4M | 654.7M | 447.7M |
Total Operating Expenses | 2.8B | 2.4B | 1.8B | 1.3B | 884.1M |
Operating Income | 2.4B | 1.3B | 873.3M | 1.6B | 1.3B |
Operating Margin % | 3.9% | 2.4% | 1.9% | 4.2% | 4.2% |
Non-Operating Items | |||||
Interest Income | - | 209.4M | 277.9M | 137.3M | 77.5M |
Interest Expense | 1.0B | 964.3M | 830.3M | 664.3M | 536.2M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 1.8B | 734.4M | 471.6M | 1.2B | 951.0M |
Income Tax | 330.6M | 78.7M | -29.4M | 232.3M | 319.9M |
Effective Tax Rate % | 18.0% | 10.7% | -6.2% | 19.7% | 33.6% |
Net Income | 1.5B | 655.8M | 501.0M | 947.2M | 631.1M |
Net Margin % | 2.4% | 1.2% | 1.1% | 2.5% | 2.1% |
Key Metrics | |||||
EBITDA | 5.4B | 3.9B | 3.1B | 3.0B | 2.3B |
EPS (Basic) | ₹12.57 | ₹5.48 | ₹4.17 | ₹8.55 | ₹5.35 |
EPS (Diluted) | ₹12.52 | ₹5.45 | ₹4.17 | ₹8.52 | ₹5.35 |
Basic Shares Outstanding | 119587908 | 119386896 | 119305676 | 112044194 | 119305676 |
Diluted Shares Outstanding | 119587908 | 119386896 | 119305676 | 112044194 | 119305676 |
Income Statement Trend
Medplus Health Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 860.5M | 912.1M | 2.3B | 214.6M | 1.1B |
Short-term Investments | 3.6B | 738.3M | 603.0M | 6.4B | 423.2M |
Accounts Receivable | 132.7M | 122.5M | 66.8M | 60.4M | 53.7M |
Inventory | 13.5B | 13.4B | 11.4B | 9.1B | 7.5B |
Other Current Assets | 364.8M | 355.3M | 317.0M | 210.8M | - |
Total Current Assets | 18.4B | 15.7B | 14.8B | 16.3B | 9.2B |
Non-Current Assets | |||||
Property, Plant & Equipment | 12.5B | 12.0B | 8.0B | 5.9B | 3.8B |
Goodwill | 923.5M | 929.8M | 904.4M | 891.6M | 867.2M |
Intangible Assets | 94.4M | 100.8M | 75.4M | 62.5M | 38.2M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 18.7M | -110.0K | -110.0K | -100.0K | -110.0K |
Total Non-Current Assets | 15.2B | 14.4B | 13.2B | 9.6B | 6.4B |
Total Assets | 33.6B | 30.0B | 28.0B | 25.9B | 15.7B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 3.0B | 2.5B | 2.6B | 2.5B | 1.5B |
Short-term Debt | 1.1B | 1.4B | 987.4M | 2.2B | 1.9B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 200.1M | 137.8M | 143.0M | 90.0M | 56.9M |
Total Current Liabilities | 5.8B | 5.3B | 4.8B | 5.6B | 4.1B |
Non-Current Liabilities | |||||
Long-term Debt | 10.1B | 8.7B | 8.0B | 6.0B | 4.0B |
Deferred Tax Liabilities | - | - | - | - | 0 |
Other Non-Current Liabilities | - | - | - | -200.0K | - |
Total Non-Current Liabilities | 10.4B | 9.0B | 8.3B | 6.2B | 4.2B |
Total Liabilities | 16.2B | 14.3B | 13.1B | 11.8B | 8.3B |
Equity | |||||
Common Stock | 239.4M | 239.1M | 238.6M | 238.6M | 4.5M |
Retained Earnings | - | 2.8B | 2.1B | 1.6B | 661.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 17.4B | 15.8B | 14.9B | 14.2B | 7.3B |
Key Metrics | |||||
Total Debt | 11.2B | 10.1B | 9.0B | 8.1B | 5.9B |
Working Capital | 12.7B | 10.4B | 10.0B | 10.7B | 5.1B |
Balance Sheet Composition
Medplus Health Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 1.8B | 734.4M | 471.6M | 1.2B | 951.0M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 68.7M | 141.0M | 221.2M | 107.4M | 399.6M |
Working Capital Changes | 646.9M | -2.2B | -2.1B | -2.1B | -1.5B |
Operating Cash Flow | 3.3B | -582.0M | -873.3M | -313.1M | 324.4M |
Investing Activities | |||||
Capital Expenditures | -584.0M | -828.4M | -1.7B | -1.1B | -540.4M |
Acquisitions | - | - | - | - | 0 |
Investment Purchases | -6.3B | -1.1B | -1.2B | -5.9B | -155.2M |
Investment Sales | 3.6B | 960.8M | 6.9B | 0 | 152.2M |
Investing Cash Flow | -3.3B | -964.0M | 4.1B | -7.1B | -542.5M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | 0 |
Financing Cash Flow | 46.3M | 72.3M | 11.9M | 5.9B | 980.0M |
Free Cash Flow | 4.8B | 593.4M | -786.0M | 521.7M | -513.7M |
Net Change in Cash | 41.1M | -1.5B | 3.2B | -1.5B | 761.9M |
Cash Flow Trend
Medplus Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
54.22
Forward P/E
53.18
Price to Book
5.49
Price to Sales
1.56
PEG Ratio
53.18
Profitability Ratios
Profit Margin
2.88%
Operating Margin
4.22%
Return on Equity
8.64%
Return on Assets
4.47%
Financial Health
Current Ratio
3.20
Debt to Equity
64.36
Beta
0.68
Per Share Data
EPS (TTM)
₹14.83
Book Value per Share
₹146.47
Revenue per Share
₹517.64
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
medplus | 96.4B | 54.22 | 5.49 | 8.64% | 2.88% | 64.36 |
Sastasundar Ventures | 8.6B | 24.05 | 1.29 | -10.55% | -8.22% | 0.11 |
Trident Lifeline | 3.2B | 25.39 | 4.93 | 16.87% | 13.27% | 77.58 |
One Global Service | 1.9B | 28.59 | 7.37 | 42.88% | 12.49% | 0.47 |
Murae Organisor | 1.3B | 15.50 | 0.62 | 5.69% | 0.88% | 102.06 |
Achyut Healthcare | 1.2B | 248.50 | 4.96 | 1.77% | 17.97% | 0.00 |
Financial data is updated regularly. All figures are in the company's reporting currency.